Page last updated: 2024-12-11

dihydroactinidiolide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dihydroactinidiolide: secretion in tail scent gland of red fox; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6432173
CHEMBL ID2271637
SCHEMBL ID2186328
MeSH IDM0056429

Synonyms (39)

Synonym
nsc-357087
actinidiolide, dihydro-
17092-92-1
dihydroactinidiolide
2(4h)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, (r)-
(7ar)-4,4,7a-trimethyl-6,7-dihydro-5h-1-benzofuran-2-one
A811266
(7ar)-4,4,7a-trimethyl-6,7-dihydro-5h-benzofuran-2-one;dihydroactinidiolide
nsc 357087
o3m4862r3r ,
2(4h)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl- (van)
unii-o3m4862r3r
S3962
CHEMBL2271637
d-dihydroactinidiolide
(r)-dihydroactinidiolide
dihydroactinidiolide (r)-form [mi]
(-)-dihydroactinidiolide
dihydroactinidiolide, (-)-
2(4h)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, (7ar)-
SCHEMBL2186328
W-108036
4,4,7a-trimethyl-5,6,7,7a-tetrahydro-1-benzofuran-2(4h)-one, (r)-
IMKHDCBNRDRUEB-LLVKDONJSA-N
5,6,7,7a-tetrahydro-4,4-7a-trimethyl-2-(4h)-benzofuranone
AKOS028109299
dihydroactinidolide
r-(-)dihydro actinidiolide
Q5276417
E77016
r-dihydroactinidiolide
(r)-4,4,7a-trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4h)-one
mfcd20926295
CCG-266435
CS-0030680
HY-107805
SB45270
DTXSID801028845
dihydroactinidiolide (r)-form
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1101945Inhibition of intact Triticum aestivum (wheat) seed germination assessed as appearance of distinct rootlets at 500 ppm after 4 days relative to wheat grains RL4137 germination2002Journal of agricultural and food chemistry, Oct-23, Volume: 50, Issue:22
Germination and growth inhibitors from wheat (Triticum aestivum L.) husks.
AID1101947Growth inhibition of intact Triticum aestivum (wheat) seed assessed as appearance of distinct rootlets at 500 ppm after 4 days relative to wheat grains RL4137 germination2002Journal of agricultural and food chemistry, Oct-23, Volume: 50, Issue:22
Germination and growth inhibitors from wheat (Triticum aestivum L.) husks.
AID1101944Inhibition of intact Triticum aestivum (wheat) seed germination assessed as appearance of sprouts at 500 ppm after 4 days relative to wheat grains RL4137 germination2002Journal of agricultural and food chemistry, Oct-23, Volume: 50, Issue:22
Germination and growth inhibitors from wheat (Triticum aestivum L.) husks.
AID1101946Growth inhibition of intact Triticum aestivum (wheat) seed assessed as appearance of sprouts at 500 ppm after 4 days relative to wheat grains RL4137 germination2002Journal of agricultural and food chemistry, Oct-23, Volume: 50, Issue:22
Germination and growth inhibitors from wheat (Triticum aestivum L.) husks.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's3 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.10 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]